Pharming Corp (PHAR) - Uzoq muddatli qarzning kapitalga koeffitsiyenti

Pharming Corp - PHAR emitenti grafik logotipi

Pharming Group N.V. (PHAR) kompaniyasining kunlik narxlar grafigi, bozor quvvati kamyob patologiyalarni davolash uchun oqsil sintezi usullarining eksklyuziv egaligiga asoslangan kompaniyaning barqarorligini aks ettiradi. Hayotni saqlab qoluvchi terapiyaga bo'lgan talab barqaror bo'lgani sababli, biznes daromadlari iqtisodiy inqirozlardan mustaqil qolmoqda. Joriy ko'rsatkich 0.35 darajasida turibdi, R&D strategiyasi esa mavjud dori vositalari uchun tibbiy ko'rsatmalarning tizimli kengaytirilishiga tayanadi.

Pharming Group NV (PHAR): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 30.10.2026gacha

Pharming Group N.V. (PHAR) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va konsensus maqsadli narx:
Kotirovkalar grafigi Pharming Group NV|PHAR - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Pharming Group N.V.|PHAR - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Pharming Group|PHAR - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati pharming.com|PHAR - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Pharming Group N.V.|PHAR - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati pharming.com|PHAR - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Pharming Group N.V.|PHAR - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Pharming Group|Tezkor likvidlik ko‘rsatkichi pharming.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
PHAR - Kompaniyaning sof foydasi
Kompaniyaning umumiy tahlili:Pharming Group NV - PHAR
Pharming Group N.V. brend mahsuloti

Ushbu koeffitsient bir yildan ortiq muddatli majburiyatlarni kapital bilan solishtirib, uzoq muddatli to'lov qobiliyatini baholash uchun balans strukturasi ichidagi qarz moliyalashtirish ulushini o'lchaydi. Ushbu metrikaning optimal muvozanati Pharming Group N.V. (PHAR) kompaniyasiga noyob kasalliklar uchun maqsadli terapiya nishalariga kengayish uchun resurslarni taqdim etadi, bu esa uzoq muddatli moliyaviy leverajning joriy darajasini belgilaydi.

Muhim raqobatchilar

argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Nektar Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati UPB|Uzoq muddatli qarzning kapitalga nisbati Zenas Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunome, Inc. (IMNM)|gossamerbio.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|PVLA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati SVRA|RIGL: Uzoq muddatli qarzning kapitalga nisbati|anaptysbio.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|ATXS (Astria Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati enGene Holdings Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati RAPT Therapeutics, Inc. (RAPT)|JBIO (aerovatetx.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Aclaris Therapeutics ACRS|KYTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Tiziana Life Sciences Ltd - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Cabaletta Bio Inc. CABA|Ventyx Bio (VTYX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi THTX|AVTX (Avalo Therapeutics, Inc) - Uzoq muddatli qarzning kapitalga nisbati|ELDN - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AGEN (Agenus Inc.)|CLYM (Climb Bio Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ZURA (Zura Bio Limited)|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati aTyr Pharmaceuticals|ADAG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti IMA (ImageneBio Inc)|shattucklabs.com (STTK) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Equillium (EQ)|Uzoq muddatli qarzning o'z kapitaliga nisbati CNTB|Uzoq muddatli qarzning kapitalga nisbati Immunic Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Atara Biotherapeutics (ATRA)|IFRX: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|X4 Pharmaceuticals, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ACET|CELU - Uzoq muddatli qarzning o'z kapitaliga nisbati|INMB (INmune Bio Corporation) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|BRNS (Barinthus Biotherapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KZR - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati SABS|Uzoq muddatli qarzning o'z kapitaliga nisbati AKTX|Uzoq muddatli qarzning o'z kapitaliga nisbati ENLV (Enlivex Therapeutics)|Uzoq muddatli qarzdorlikning kapitalga nisbati q32bio.com|Uzoq muddatli qarzning o'z kapitaliga nisbati GeoVax Labs, Inc. GOVX|EDSA (edesabiotech.com) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|iBio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CARM (Carisma Therapeutics)|XTLB: Uzoq muddatli qarzning kapitalga nisbati|Bolt Biotherapeutics, Inc. (BOLT) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|APVO: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech (AIM)|ADTX: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati GRI (GRI Bio Corp)|Uzoq muddatli qarzning kapitalga koeffitsiyenti XRTX|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|REVB - Uzoq muddatli qarzning kapitalga nisbati|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Scinai Immunotherapeutics Ltd - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati CalciMedica Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Affimed Therapeutics (AFMD)|Uzoq muddatli qarzning kapitalga nisbati ALLK|Uzoq muddatli qarzning kapitalga nisbati hookipapharma.com (HOOK)|IGM Biosciences - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ITOS|Ocean Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati TC BioPharm Ltd TCBP|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati